The Alliance for Cancer Gene Therapy is collaborating with the Cancer Research Institute and the Parker Institute for Cancer Immunotherapy on a new study to address the challenge of treating brain cancer with immunotherapy. Researchers at City of Hope, Children’s Hospital of Philadelphia, Stanford, UCLA, and UCSF are identifying new immunotherapy targets for the treatment of aggressive brain tumors in children and adults. This work on cell and gene therapy may apply to all solid tumors in future.
In 2001, Barbara and Edward Netter founded ACGT to accelerate progress and fund the best research at the most prestigious institutions developing cell and gene therapies for cancer. Since then, ACGT has awarded $30.2 million through 59 grants to 54 research fellows representing 36 top medical institutions in the United States and Canada.